Adagio Studying its Monoclonal Antibody for Prevention and Treatment of COVID-19

Retrieved on: 2021-06-08 11:03:45

Tags for this article:

Medicine

Medical specialties

COVID-19 drug development

Click the tags to see associated articles and topics

Adagio Studying its Monoclonal Antibody for Prevention and Treatment of COVID-19. View article details on HISWAI: https://www.contagionlive.com/view/adagio-studying-its-monoclonal-antibody-for-prevention-and-treatment-of-covid-19

Excerpt

The company's investigational therapy, ADG20, is a monoclonal antibody developed for both the treatment and prevention of COVID-19. ADG20 was ...

Article found on: www.contagionlive.com

View Original Article